Adial Pharmaceuticals Inc... (ADIL)
NASDAQ: ADIL
· Real-Time Price · USD
0.56
-0.10 (-14.92%)
At close: Jun 06, 2025, 3:13 PM
-14.92% (1D)
| Bid | 0.47 |
| Market Cap | 4.38M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.95M |
| EPS (ttm) | -0.87 |
| PE Ratio (ttm) | -0.64 |
| Forward PE | -0.67 |
| Analyst | Buy |
| Ask | 0.58 |
| Volume | 815,239 |
| Avg. Volume (20D) | 600,815 |
| Open | 0.66 |
| Previous Close | 0.66 |
| Day's Range | 0.51 - 0.69 |
| 52-Week Range | 0.51 - 3.00 |
| Beta | 1.19 |
About ADIL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ADIL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ADIL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+20.64%
Adial Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
6 months ago
+15.04%
Adial Pharmaceuticals shares are trading higher after the company announced results from its AD04-103 pharmacokinetics study for AD04, aimed at treating alcohol use disorder.
